Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 10, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

September 30, 2025

Conditions
Pancreatic CancerMetastasisSurgeryOligometastatic Disease
Interventions
DRUG

nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)

preoperative chemotherapy

Trial Locations (11)

Unknown

RECRUITING

University Aachen, Aachen

ACTIVE_NOT_RECRUITING

University of Berlin, Charité, Campus Benjamin-Franklin, Berlin

ACTIVE_NOT_RECRUITING

University of Bonn, Bonn

RECRUITING

Städtisches Klinikum Dresden, Dresden

ACTIVE_NOT_RECRUITING

University of Düsseldorf, Düsseldorf

RECRUITING

University of Freiburg, Freiburg im Breisgau

RECRUITING

University of Halle (Saale), Halle

RECRUITING

University of Heidelberg, Heidelberg

ACTIVE_NOT_RECRUITING

Klinikum Großhadern, LMU München, München

RECRUITING

Klinikum Rechts der Isar Technische Universität München, München

RECRUITING

University of Regensburg, Regensburg

All Listed Sponsors
collaborator

Servier

INDUSTRY

lead

University of Cologne

OTHER